Dysregulation of redox homeostasis, often associated with aberrant GSH metabolism and SLC7A11 activity, contributes to various pathologies, including cancer, where SLC7A11 overexpression promotes tumor survival by enhancing resistance to oxidative stress. The gene discussed is SLC7A11; the disease is neoplasm.